NXPL stock forecast, quote, news & analysis
NextPlat Corp is an e-commerce and healthcare company... Show more
Why NextPlat (NXPL) Stock Is Down -29% in the Last 30 Days
Key Takeaways
- NextPlat shares have dropped roughly 29% over the past 30 days, falling from about $9.01 on October 13 to near $6.38.
- The bulk of the decline came in a sharp single-session selloff of about 21% after third-quarter results were released.
- Third-quarter 2026 revenue declined year over year to approximately $10.5 million, even as gross margin held near 35% and the net loss narrowed by about 66%.
- The stock had rallied strongly earlier in the quarter, climbing from roughly $6 in early August to above $9 by mid-October, before reversing course.
- Key factors to monitor include potential share dilution from an at-the-market equity program, a recent reverse stock split, and execution on the healthcare growth strategy.
- NextPlat operates two segments: satellite-connectivity e-commerce and U.S. pharmacy and healthcare services through its Progressive Care subsidiary.
- For additional context, explore NXPL Price Targets, Earnings, and Forecast pages.
- Discover how AI-powered strategies are tracking this and other tickers by visiting Trending AI Robots.
NextPlat (NXPL) Company Overview and Market Position
NextPlat Corp is a global consumer products and services company that provides healthcare and technology solutions through e-commerce and retail channels worldwide. Headquartered in Coconut Grove, Florida, the company operates two main businesses: an e-commerce communications division offering voice, data, tracking, and Internet of Things (IoT) products, including satellite-connectivity devices from manufacturers such as Globalstar and Iridium, and a U.S. healthcare segment run through its wholly owned subsidiary Progressive Care, which provides pharmacy and healthcare data-management services.
The company's healthcare platform, PharmcoRx, serves retail, 340B, long-term care, government, and specialty pharmacy customers, supported by its proprietary ClearMetrX data-analytics software. NextPlat has also built an e-commerce program distributing OPKO Health-branded products in Asia. Investors follow NXPL for its turnaround toward profitability, gross-margin expansion, and growth in higher-margin contracted healthcare services.
NextPlat (NXPL) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, NXPL has declined approximately 29%, moving from a closing price near $9.01 on October 13 to roughly $6.38. The move was concentrated rather than gradual: the stock traded in the $8.00 to $9.00 range for much of the period before a sharp decline of about 21% in a single session following the release of third-quarter results.
The trailing-quarter picture is more nuanced. NextPlat began the period in early August near $6.00, rallied strongly through late summer, and reached a local peak of about $9.68 in mid-October as investors positioned for improving margins and healthcare growth. The subsequent reversal erased those gains, leaving the stock roughly 5% lower over the trailing three months despite the earlier rally.
What Drove NXPL Stock Price in the Last 30 Days
The dominant catalyst was the company's third-quarter 2026 earnings release in mid-November, which triggered a sharp single-day selloff. While NextPlat reported consolidated gross margins of approximately 35% and a roughly 66% reduction in net loss, revenue declined year over year to about $10.5 million from $13.8 million, reflecting lower sales in the prior-year comparison period.
Investor concerns also centered on share-count dynamics. NextPlat completed a reverse stock split in 2026 to regain compliance with Nasdaq's minimum bid price requirement and established an at-the-market equity program with H.C. Wainwright to support potential growth initiatives. These factors can weigh on sentiment for a micro-cap company where share-supply dynamics matter. The combination of a revenue decline, a still-loss-making bottom line, and dilution overhang outweighed the positive margin and cost-control story during the period.
What Drove NXPL Stock Performance Over the Last Quarter
Over the broader quarter, NextPlat's stock was shaped by an improving operational narrative that later gave way to profit-taking and a post-earnings reset. In late summer, shares rallied on evidence of progress in the company's turnaround, including record 340B contract wins, the deployment of its AI-powered ClearMetrX 4.0 platform, and the completion of an acquisition of a profitable Florida pharmacy near Pensacola that added roughly $5.6 million in annual revenue.
The company also expanded its satellite-connectivity e-commerce reach through a partnership with sporting-goods retailer Decathlon, selling satellite products to online customers across 20 countries, and reported strong demand for connectivity hardware. That momentum carried the stock to multi-month highs by mid-October before the third-quarter revenue decline and dilution concerns triggered a sharp reversal, leaving shares roughly flat to slightly lower over the trailing three-month window.
Trending AI Robots
Tickeron's Trending AI Robots page curates a selection of top-performing AI-powered trading bots from a broader universe of hundreds of bots trading thousands of tickers. Because only the most relevant and consistently performing strategies appear in this section, it offers a focused way to observe how automated systems are positioning across the market. The bots vary widely in strategy, timeframe, and performance metrics, allowing traders to compare approaches suited to different objectives. For investors tracking volatile names like NXPL, exploring these AI-driven strategies can provide additional perspective on market signals.
NXPL Stock Forecast Drivers: What Investors Should Watch Next
Looking ahead, investors will focus on whether NextPlat can return revenue to growth while sustaining its improved gross margins near 35%. The planned fourth-quarter launch of a nationwide medication-fulfillment website is a key near-term catalyst, as it would extend PharmcoRx beyond Florida and create a national e-commerce channel for prescription and over-the-counter products.
Other factors to monitor include the ramp of newly contracted 340B entities, continued demand for satellite-connectivity products, potential further acquisitions in the Florida pharmacy market, and the pace of any share issuance under the at-the-market program. Macroeconomic and reimbursement pressures in the U.S. pharmacy sector, along with the company's path toward positive operating income, will also shape sentiment. These are forward-looking considerations rather than predictions, and outcomes remain uncertain.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
NXPL's Stochastic Oscillator sits in overbought zone for 1 day
Expect a price pull-back in the near future.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NXPL as a result. In 85 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for NXPL turned negative on November 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 52 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
NXPL moved below its 50-day moving average on October 19, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for NXPL crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NXPL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for NXPL entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NXPL's RSI Oscillator exited the oversold zone, 28 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
Following a +14.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where NXPL advanced for three days, in 199 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
NXPL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.364) is normal, around the industry mean (-1.906). P/E Ratio (-2.402) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.180) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (0.494) is also within normal values, averaging (70.383).
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. NXPL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NXPL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
What is the difference between active and passive money management?
If Everyone is Talking about Buying Gold, Should I Buy Some for My Portfolio as Well?
Who Are the Top 10 Most Renowned Traders in the World's History?
How Does the Debt Ratio Shape Our View of a Company's Financial Health?
What Is a Chartered Financial Analyst (CFA)?
General Information
Industry PackagedSoftware